高清福利片

A person sitting at a table in a white lab coat, with a plate, knife and fork in front of them, and a red apple on the plate.
高清福利片_

Going with your gut

An extraordinary gift for bowel cancer research

Ellie 脿 Beckett left the majority of her estate as a gift in her will to advance bowel cancer research. More than 10 years on, researchers are edging closer to improved patient outcomes, with help from some surprising collaborators - your gut microbiome.

It鈥檚 a fact that鈥檚 hard to stomach: you are more bacteria than human. The approximately 39 trillion cells in these tiny organisms just outnumber the 30 trillion human ones in an adult body. Scientists are now beginning to understand how these billions of bacteria and other microbes, collectively known as the microbiome, work together to affect functions as diverse as digestion, heart function, mental health, and even the development 鈥 or treatment 鈥 of cancer.

Dr Erin Shanahan (BSc(Adv)(Hons) 鈥07, PhD 鈥14) has a personal stake in beating bowel cancer, also known as colorectal cancer: it has affected her family throughout her lifetime, with three grandparents and an aunt all having suffered through the disease. But it is her warmth and humour that shine through as she discusses her work on the microbiome, acknowledging it鈥檚 鈥渘ot necessarily dinner-time conversation.鈥

Dr Erin Shanahan standing with a white lab coat

Dr Erin Shanahan

鈥淭he surface area of the gut is absolutely enormous 鈥 flattened out, it could cover a studio apartment. This creates a massive area for microbes聽to聽grow in.鈥

The organisms living in our guts are not innately harmful, but issues can arise when the hundreds of species become imbalanced. Our diet has an important role to play in managing these microbial hitchhikers: over time, the wrong diet can encourage a proliferation of species which impact surrounding gut cells, pushing them towards becoming cancerous.

As Shanahan quips, 鈥渨hat we eat is what they eat! We already know some risk factors, like diets which are low in fibre and high in processed meats. But we don鈥檛 understand why, if you put 100 people on that 鈥榖ad鈥 diet, they won鈥檛 all develop bowel cancer. And the answer to that might lie in the microbiome.鈥

A microbiologist and 脿 Beckett Fellow, Shanahan conducts her research from the Charles Perkins Centre at the University of Sydney.

The fellowship was created when Emma Elwin 鈥淓llie鈥 脿 Beckett left a $15 million bequest to the University following her death in 2013. Named after Ellie鈥檚 brother, the William Arthur Martin 脿 Beckett Cancer Research Trust has supported four Fellows and the establishment of a germ-free facility 鈥 a space completely free of microbes, critical for studying the relationship between the microbiome and disease.

With work spanning preclinical studies through to patient-led care interventions for bowel cancer, the 脿 Beckett Fellows stand as an extraordinary monument both to Ellie鈥檚 love for her brother, and to the profound impact of endowed giving.

Bowel cancer is the third most diagnosed in Australia, with 15,000 new cases every year. When Martin 脿 Beckett died in 1986, the five-year survival rate for bowel cancer stood at 55聽percent with treatment largely focused on surgery, and chemoradiation just beginning to聽gain traction.聽

鈥淭his gift will keep on giving... the knowledge and ideas generated by the fellowship will be informing studies, and helping patients, long after the money has been spent."
Dr Erin Shanahan

Today the five-year survival rate is 70聽percent due to an increase in colonoscopies and screening, and the growing number of treatment options, including more targeted therapies.

Using personalised nutrition to treat cancer is central to Shanahan鈥檚 two-pronged research. The first element of her study uses pre-clinical models and clinical data analysis to investigate what constitutes a healthy microbiome, including which dietary elements can encourage gut health, or affect tumour development.

Shanahan hopes this knowledge will help patients lower their risk of bowel cancer. For example, following a colonoscopy where polyps are discovered, doctors in future might advise a patient on specific dietary changes or supplements that could reduce the chances of developing聽a聽tumour.

鈥淚f we can inform an individual that eating red meat is particularly risky for them based on their unique microbiome, that鈥檚 more powerful than generic advice to eat a healthy, high-fibre diet.鈥

But it鈥檚 the second component聽of her work which Shanahan seems most聽passionate about.

鈥淚n terms of a 鈥榖reakthrough鈥, I鈥檓 really excited about my work in immunotherapy, and reactivating the immune system to try to target and kill cancer cells. Immunotherapy has been revolutionary in cancer treatment in recent years, and we鈥檙e interested in the emerging evidence that the gut microbiome has a role to play.鈥

Two researchers in white lab coats holding vials.

The gut microbiome interacts with our immune system, and can stimulate the right types of immune responses to potentially eliminate a tumour 鈥 even one located nowhere near the gut.

However, many immunotherapy patients suffer prohibitive side effects, or are unresponsive to treatment.

Shanahan is researching whether聽biological signatures in the microbiome can predict which patients are likely to respond positively to immunotherapy. Longer term, the aim is to help more patients become part of this responsive group, through diet and other聽interventions.

鈥淎lthough we are still designing clinical trials, I feel there is a direct pathway to change ahead. One clinician I work with has already begun talking to her patients about what might be possible for them in future.鈥

For Shanahan, the 脿 Beckett Fellowship has provided the stability to build a comprehensive research program, in a field not traditionally associated with microbiology.

鈥淲ithout Ellie鈥檚 gift, I wouldn鈥檛 be bringing my knowledge of聽microbiology to colorectal cancer 鈥 she聽has enabled me to apply my expertise to聽a new,聽emerging area.

鈥淚t鈥檚 an incredibly generous thing to do,鈥 says Shanahan, beaming. 鈥淭his gift will keep on giving, beyond its original scope. As researchers, we are always building on what has come before. The knowledge and ideas generated by the Fellowship will be informing studies, and helping patients, long after the money has been spent.鈥澛


6 October 2022